Bifidobacteria growth

"Bifidobacterium" refers to a genus of Gram-positive anaerobic bacteria commonly found in the human gastrointestinal tract. They play an important role in carbohydrate metabolism—especially through the unique 'bifid shunt' pathway involving fructose 6-phosphate phosphoketolase—and contribute to gut health by producing short-chain fatty acids such as acetate and lactate[1][2]. These metabolites support colonocyte energy needs and have anti-inflammatory properties. Bifidobacterial surface molecules interact with host immune cells, modulating both innate and adaptive immunity[3]. Some strains have demonstrated antitumor effects through modulation of cytokine expression and inhibition of carcinogenesis pathways[4]. The term "Bifidobacteria growth," however, does not refer to any single molecule or canonical therapeutic target but rather describes the proliferation or population dynamics of this bacterial group within an ecosystem such as the human gut. **Note:** The entry "Bifidobacteria growth" is **not** itself a valid therapeutic target like an enzyme or receptor. It refers instead to changes in population size or activity level within this bacterial genus. If you seek information about specific enzymes involved in bifidobacterial metabolism—such as fructose 6-phosphate phosphoketolase—or about cell-surface molecules mediating host interactions, those would be more appropriate targets for structured data extraction. If you need structured information on actual drug targets related to bifidobacterial function—such as key metabolic enzymes—please specify which protein/molecule is intended.

Other names

Bifidobacterium speciesBifidobacteriaProbiotic bifidobacteria